Alpha-Tocopherolquinone
Friedreich's Ataxia
Penwest Pharmaceuticals Co.Phase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Friedreich's Ataxia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Idebenone Santhera Pharmaceuticals | Phase 3 | A |
Interferon Γ-1B Amgen | Phase 3 | BB |
rt001 Biojiva LLC | Phase 3 | BB |
Deferiprone ApoPharma | Phase 2 | BB |
Pioglitazone Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
View all 12 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →